Effects of Balance Training on Functional Capacity of Patients After Coronary Artery Bypass Grafting Surgery

June 30, 2024 updated by: Hady Atef Labib, Cairo University

Effects of Balance Training Post Coronary Artery Bypass Grafting

Background:There are still many gaps in research concerning the effect of balance training on functional capacity of patient after coronary artery bypass graft.

Aims: The purpose of this study was to examine the effect of balance training on patients after coronanry artery bypass graft surgery.

Study Overview

Status

Completed

Detailed Description

Methods: Sixty male patients under went CABG with ages 55-65 years Patients were randomly randomized into to two groups equal in number 30 in each group. (Group A: study group, Group B: control group).All patients were thoroughly evaluated one day after extubation and day 6 after operation.

Berg Balance Scale (BBS): is a test used to assess patients functional balance , the sit to stand test(STS) used to asses patients functional capacity and SF36 is questionnaire used to assess quality of life with patients. all of those tests done before and after training sessions with both groups. and compare the length of hospital stay between both groups.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt, 11262
        • National Heart Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Sixty male patients underwent CABG surgery, their age between 55 to 65 years old.
  2. All patients were conscious, clinically and medically stable.
  3. All patients are ambulant independently.
  4. All patients are haemodynamically stable.
  5. Good cognition level.
  6. All patients are conscious and can perform physical activity.

Exclusion Criteria:

  1. Hemodynamic instability.
  2. Patients who need re-intubation.
  3. Patients on high inotropic supports.
  4. Patients with existing pulmonary disease or associated pulmonary complications.
  5. Recent MI.
  6. Patients who reported too much pain.
  7. Neuromuscular disorders.
  8. Active hemorrhage and hemoptysis.
  9. Poor cognition and mentality.
  10. Unstable angina.
  11. Decompensated heart failure.
  12. Deep vein thrombosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A :( Study group)
Underwent balance training and cardiac rehabilitation program for a duration of 25-30 min (total session) at a frequency of three times/week (every other day). The balance training was: a- Functional strength exercise b- Stance exercise c- Transition exercise D-Gait training e- Cardiac rehabilitation program .
Balance exercises and cardiac rehabilitation (intervention) for patients for 7 Days, 3 times/week for duration of 25-30 min/ session.
Other Names:
  • cardiac rehabilitation
Active Comparator: Group B (control group)

underwent cardiac rehabilitation program only for a duration of 25-30 min (total session) at a frequency of three times/week (day after day).

the control group, received cardiac rehabilitation program only.

Balance exercises and cardiac rehabilitation (intervention) for patients for 7 Days, 3 times/week for duration of 25-30 min/ session.
Other Names:
  • cardiac rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg balance scale(BBS)
Time Frame: 7 Days
(0 indicating the lowest level ,4 indicating the highest level ) data about balance from BBS index.
7 Days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sit to stand test(SST)in seconds
Time Frame: 1st day and 7th day
represent functional capacity (duration of 5 times sit to stand)
1st day and 7th day
length of hospital stay (in Days)
Time Frame: from 1st day
number of days spent in hospital
from 1st day
SF36 Questionnaire( scores)
Time Frame: 3rd day
Scores range from 0 - 100 Lower scores = more disability, higher scores = less disability
3rd day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hady Balabel, phD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

December 10, 2023

Study Completion (Actual)

December 10, 2023

Study Registration Dates

First Submitted

June 30, 2024

First Submitted That Met QC Criteria

June 30, 2024

First Posted (Actual)

July 8, 2024

Study Record Updates

Last Update Posted (Actual)

July 8, 2024

Last Update Submitted That Met QC Criteria

June 30, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • balance and cabg patients

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

after approval can be shared

IPD Sharing Time Frame

after 1 month for 12 months

IPD Sharing Access Criteria

will upload it to the journal of publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Bypass Graft Surgery(CABG)

Clinical Trials on Balance Training

Subscribe